Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/seal-rock-therapeutics-to-present-preclinical-efficacy-findings-for-srt-015-in-cholestatic-liver-diseases-at-the-european-association-for-study-of-the-liver-easl-congress-2024-302157529.html
https://www.fiercebiotech.com/biotech/genfit-adds-3rd-liver-failure-asset-roster-107m-biobucks-deal-seal-rock
https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-out-licensing-agreement-with-genfit-for-development-of-injectable-formulation-of-srt-015-for-acute-on-chronic-liver-disease-aclf-301839273.html
https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-upcoming-oral-and-poster-presentations-at-aaslds-the-liver-meeting-2022-301656962.html
https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-completion-of-single-ascending-dose-cohort-in-phase-1-clinical-trial-of-ask1-inhibitor-srt-015-for-nash-301403152.html
https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-initiation-of-phase-1-clinical-trial-of-ask1-inhibitor-srt-015-for-nash-301318169.html